ACMG Urges Caution When Editing Embryo Genomes

The American College of Medical Genetics and Genomics calls on scientists and health care providers to engage in public discussion about the ethical issues involved in genome editing. 

By | January 30, 2017

PIXABAY The board of directors of the American College of Medical Genetics and Genomics (ACMG) released a statement last Thursday outlining their concerns about genome editing technologies in Genetics in Medicine (January 26).

“Genome editing offers great promise for the future treatment of individuals and families with genetic disorders,” the authors write, “but also raises major technological and ethical issues that must be resolved before clinical application.”

Thanks to the CRISPR system, a powerful gene editing tool, scientists may soon be able to edit genes to cure diseases. But the ACMG board pointed out some limitations of gene editing technologies such as CRISPR, including off-target effects and potential safety issues (introducing new genetic variations while editing pathological genes, for example). They also pointed out that with embryos, these safety and technological challenges come with the distinct possibility of impacting future generations through the germline.

The board also encouraged broad, society-level discussion about whether it is appropriate to manipulate non-disease related genes. “It is inevitable … that consideration will also be given to editing variants associated with phenotypes that are not fully penetrant and for which effects on quality of life are less clear,” the authors wrote. “Such issues are not typically of concern in the management of children or adults with genetic conditions, but will become critical if gene editing in the embryo is contemplated.”

 

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Comments

Avatar of: primativebeliever

primativebeliever

Posts: 30

January 30, 2017

why would we play around with someones life on a gene level when experimenting on humans on other levels has produced great sufferings and horrors? The nazis and Japanese of WW2 comes to mind.

Avatar of: PastToTheFuture

PastToTheFuture

Posts: 101

January 30, 2017

While CRISPR is going to make some biotech firms many truckloads of money it will be found to be uneconomical and unnecessary in  regards to humans... If you want to see why, look at "Genetics for a New Human Ecology at https://www.amazon.com/dp/B01MYCC25Q

Popular Now

  1. Can Young Stem Cells Make Older People Stronger?
  2. Thousands of Mutations Accumulate in the Human Brain Over a Lifetime
  3. Two Dozen House Republicans Do an About-Face on Tuition Tax
  4. CRISPR to Debut in Clinical Trials